-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Neutral on Alpha Tau Medical, Raises Price Target to $8

Benzinga·05/19/2026 12:00:23
Listen to the news
Piper Sandler analyst Jason Bednar maintains Alpha Tau Medical (NASDAQ:DRTS) with a Neutral and raises the price target from $5 to $8.